Ibogaine act

Ibogaine Act

Source of recordUS Congress · congress.govLast synced Sep 1, 2026

Chamber

House

Progress

Where this bill stands in the legislative process.

Introduced
Passed House
Passed Senate
To President
Became Law

Overview

This bill, known as the Ibogaine Act, aims to accelerate the development and access to psychedelic drugs, particularly ibogaine, for treating serious mental illnesses. It proposes several measures including a National Health Priority Voucher Pilot Program to expedite FDA review of promising drugs, amendments to the Federal Right to Try law, and revisions to DEA quota requirements. The bill also seeks to foster collaboration between the federal government, state governments, and the private sector to advance research and treatment options for mental health conditions.

Key provisions

Establishes a National Health Priority Voucher Pilot Program to expedite FDA review of qualifying drugs.
Amends the Federal Right to Try law to allow for direct administration of ibogaine by physicians.
Revises DEA quota requirements for controlled substances, particularly in response to triggering events like drug approvals or clinical trial advancements.
Creates a senior official within the Department of Veterans Affairs to oversee emerging therapeutic interventions.
Mandates a report on the implementation of Executive Order 14401 regarding accelerating medical treatments for serious mental illness.
Defines ‘ibogaine’ to include the plant and related compounds with specific neuroplasticity effects.
Establishes a process for registering physicians to administer ibogaine under the Right to Try law.
Authorizes the Secretary of Veterans Affairs to develop a workforce readiness plan for psychedelic-assisted therapies.

Bill text

Read the latest version inline or switch to a previous version.

Jun 30, 2026XMLView source

Text extraction is in progress. View the official source.

Legislative history

6 recorded actions

Jun 30, 2026House

Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Jun 30, 2026House

Jun 30, 2026

Introduced in House

Jun 30, 2026

Introduced in House

Jul 17, 2026House

Referred to the Subcommittee on Health.

Geography

Recorded positions across the country.

No public positions recorded for this legislation.

Arguments

Reasons offered for and against this legislation.

Arguments in favor

No arguments in favor have been submitted.

Submit yours

Arguments opposed

No arguments opposed have been submitted.

Submit yours

Ibogaine act

Progress